Company news
Onconetix, Inc. news in 2026
Onconetix, Inc.'s news releases, calls and decks from 2026, newest first.
Onconetix Acquisition Target Realbotix Launches Echo Humanoid Robot Line with Tabletop and Full Body Models Designed for Education, Wellness, and Social Engagement
October 27, 2026
Onconetix Announces Reverse Stock Split
October 26, 2026
Onconetix Provides Additional Strategic Bridge Financing to Realbotix LLC in Continued Support of Pending Acquisition
October 23, 2026
OncoC4 Receives FDA Fast Track Designation for Cesalatamig, an Investigational PD-1/VEGF Bispecific Antibody
September 16, 2026
CORRECTED: Onconetix Provides Strategic Bridge Financing to Realbotix LLC in Support of Pending Acquisition
September 14, 2026
Onconetix Provides Strategic Bridge Financing to Realbotix LLC in Support of Pending Acquisition
September 14, 2026
Onco360® Has Been Selected as Part of an Ultra-Narrow Specialty Pharmacy Network for MIMRYLO™ (rusfertide)
September 9, 2026
Onconetix Acquisition Target Realbotix Launches Pilot with Leading European Telecommunications Company to Deploy Humanoid Robots in Live Presentations and Events
September 3, 2026
OncoC4 Announces First Patient Dosing in Phase 1 Clinical Trial of ONC-783 for the Treatment of Advanced Solid Tumors
August 17, 2026
Onconetix Acquisition Target Realbotix Secures Agreement for Humanoid Robot Appearance on Emmy Award-Winning Streaming Series
August 6, 2026
Onconetix Announces Appointment of Ralph Schiess, PhD to Board of Directors of Proteomedix AG
August 5, 2026
Onconetix Highlights Realbotix Partnership with Bloom Services to Launch UK Pilot Using Humanoid Robots to Combat Elderly Social Isolation
July 7, 2026
Onconetix Highlights Realbotix's Launch of Humanoid Robot and AI Teachers Assistant Pilot Program in New York State School District
June 24, 2026
Onconetix Highlights Realbotix’s Launch of Humanoid Robot and AI Teachers Assistant Pilot Program in New York State School District
June 24, 2026
Onconetix, Inc. Announces 1-for-10 Reverse Stock Split
May 19, 2026
Onconetix Reports Q1 2026 Progress at Proteomedix AG, Including Two New Peer-Reviewed Publications and Initiation of U.S. Validation Study
May 13, 2026
Onconetix Highlights Realbotix's Launch of Vinci AI Vision System with Delivery of First Vinci-Equipped Humanoid Robot to Ericsson
April 9, 2026
Onconetix Highlights Realbotix AI Humanoid Robot Delivery Update
April 2, 2026
Onconetix Appoints David White as Chief Executive Officer and Sammy Dorf as Member of the Board of Directors
March 31, 2026
Onconetix Highlights Realbotix’s Role in Ericsson’s World-First 6G Trial Demonstration
March 25, 2026
Onconetix Highlights Realbotix's Role in Ericsson's World-First 6G Trial Demonstration
March 25, 2026
Onconetix, Inc. Announces 1-for-5 Reverse Stock Split
March 23, 2026
Onconetix to Acquire Realbotix LLC, USA-based, AI-Powered Humanoid Robotics Company
February 12, 2026